{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:45:59Z","timestamp":1791996359174,"version":"4.4.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e0 degli Studi di Roma La Sapienza"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To investigate the clinical outcomes of patients with brain metastases undergoing surgery followed by postoperative three-fraction or five-fraction radiosurgery (SRS) to the resection cavity. Factors associated with local failure and symptomatic radionecrosis were evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and methods<\/jats:title>\n                    <jats:p>One hundred and ninety consecutive patients with 202 brain metastases who received surgery followed by three- or five-fraction SRS to the surgical bed were analyzed. All cavities included in the study received either 27\u00a0Gy in 3 fractions or 30\u00a0Gy in 5 fractions given daily on consecutive days. Cumulative incidence analysis was used to compare local control and symptomatic radionecrosis between groups from the time of SRS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Ten cavities after 3-fraction and 14 lesions after 5-fraction SRS group recurred (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.38) with a median time to progression of 12 months. Cumulative LC rates were 93% (87\u201397) and 90.2% (87.5\u201394.5) at 1 year, and 90% (84\u201396) and 85.5% (76.2\u201391.3) at 2 years (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.4) for 3-fraction and 5-fraction SRS groups, respectively. Symptomatic radionecrosis developed in 28 patients (3-fraction SRS,16; 5-fraction SRS,12), requiring surgery or medical treatment; the 1-year and 2-year cumulative rates were 12.8% (8.3\u201322.4%) and 17.9% (12.3\u201328.9%), respectively, after 3-fraction SRS, and 9.8% (6.5\u201319.1%) and 13.0% (7.3\u201322.2%), respectively, after 5-fraction SRS (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.3). Sixteen patients after 3-fraction and fourteen patients after 5-fraction SRS developed leptomeningeal disease (LMD); 1-year LMD cumulative rates were 13.5% and 13.8%.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Both 3\u2009\u00d7\u20099\u00a0Gy and 5\u2009\u00d7\u20096\u00a0Gy are effective SRS treatment modalities for resected brain metastases associated with high local control and low risk of symptomatic radionecrosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11060-025-05357-7","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T08:18:25Z","timestamp":1768983505000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical outcomes of three-fraction versus five-fraction stereotactic radiosurgery for resected brain metastases"],"prefix":"10.1007","volume":"176","author":[{"given":"Giuseppe","family":"Minniti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Tini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piera","family":"Navarria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Raza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe Maria Della","family":"Pepa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Chiesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"De Felice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Zaccaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Capone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Tomaciello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Lanzetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Giraffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Marampon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Paolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"issue":"11","key":"5357_CR1","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.annonc.2021.07.016","volume":"32","author":"E Le Rhun","year":"2021","unstructured":"Le Rhun E, Guckenberger M, Smits M, Dummer R, Bachelot T, Sahm F, Galldiks N, de Azambuja E, Berghoff AS, Metellus P, Peters S, Hong YK, Winkler F, Schadendorf D, van den Bent M, Seoane J, Stahel R, Minniti G, Wesseling P, Weller M, Preusser M (2021) EANO executive board and ESMO guidelines Committee. Electronic address: clinicalguidelines@esmo.org. EANO-ESMO clinical practice guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours. Ann Oncol 32(11):1332\u20131347. https:\/\/doi.org\/10.1016\/j.annonc.2021.07.016","journal-title":"Ann Oncol"},{"issue":"5","key":"5357_CR2","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1200\/JCO.21.02314","volume":"40","author":"MA Vogelbaum","year":"2022","unstructured":"Vogelbaum MA, Brown PD, Messersmith H, Brastianos PK, Burri S, Cahill D, Dunn IF, Gaspar LE, Gatson NTN, Gondi V, Jordan JT, Lassman AB, Maues J, Mohile N, Redjal N, Stevens G, Sulman E, van den Bent M, Wallace HJ, Weinberg JS, Zadeh G, Schiff D (2022) Treatment for brain metastases: ASCO-SNO-ASTRO guideline. J Clin Oncol 40(5):492\u2013516. https:\/\/doi.org\/10.1200\/JCO.21.02314","journal-title":"J Clin Oncol"},{"issue":"2","key":"5357_CR3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3171\/2009.11.JNS09659","volume":"113","author":"AJ Patel","year":"2010","unstructured":"Patel AJ, Suki D, Hatiboglu MA, Abouassi H, Shi W, Wildrick DM, Lang FF, Sawaya R (2010) Factors influencing the risk of local recurrence after resection of a single brain metastasis. J Neurosurg 113(2):181\u2013189. https:\/\/doi.org\/10.3171\/2009.11.JNS09659","journal-title":"J Neurosurg"},{"key":"5357_CR4","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.3171\/2010.11.JNS10939","volume":"114","author":"CA Jensen","year":"2011","unstructured":"Jensen CA, Chan MD, McCoy TP, Bourland JD, deGuzman AF, Ellis TL, Ekstrand KE, McMullen KP, Munley MT, Shaw EG, Urbanic JJ, Tatter SB (2011) Cavity-directed radiosurgery as adjuvant therapy after resection of a brain metastasis. J Neurosurg 114:1585\u20131591. https:\/\/doi.org\/10.3171\/2010.11.JNS10939","journal-title":"J Neurosurg"},{"key":"5357_CR5","doi-asserted-by":"publisher","unstructured":"Luther N, Kondziolka D, Kano H, Mousavi SH, Engh JA, Niranjan A, Flickinger JC, Lunsford LD (2013) Predicting tumor control after resection bed radiosurgery of brain metastases. Neurosurgery 73:1001\u20136; discussion 1006. https:\/\/doi.org\/10.1227\/NEU.0000000000000148. PMID: 24264235","DOI":"10.1227\/NEU.0000000000000148"},{"key":"5357_CR6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3171\/2014.7.GKS141488","volume":"121 Suppl","author":"C Iorio-Morin","year":"2014","unstructured":"Iorio-Morin C, Masson-C\u00f4t\u00e9 L, Ezahr Y, Blanchard J, Ebacher A, Mathieu D (2014) Early gamma knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control. J Neurosurg 121 Suppl:69\u201374. https:\/\/doi.org\/10.3171\/2014.7.GKS141488","journal-title":"J Neurosurg"},{"key":"5357_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3171\/2014.6.GKS14708","volume":"121","author":"E Ojerholm","year":"2014","unstructured":"Ojerholm E, Lee JY, Thawani JP, Miller D, O\u2019Rourke DM, Dorsey JF, Geiger GA, Nagda S, Kolker JD, Lustig RA, Alonso-Basanta M (2014) Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis. J Neurosurg 121:75\u201383. https:\/\/doi.org\/10.3171\/2014.6.GKS14708","journal-title":"J Neurosurg"},{"key":"5357_CR8","doi-asserted-by":"publisher","unstructured":"Brown PD, Ballman KV, Cerhan JH, Anderson SK, Carrero XW, Whitton AC, Greenspoon J, Parney IF, Laack NNI, Ashman JB, Bahary JP, Hadjipanayis CG, Urbanic JJ, Barker FG 2nd, Farace E, Khuntia D, Giannini C, Buckner JC, Galanis E, Roberge D (2017) Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C\/CEC\u00b73): a multicentre, randomised, controlled, phase 3 trial. Lancet Oncol 18:1049\u20131060. https:\/\/doi.org\/10.1016\/S1470-2045(17)30441-2","DOI":"10.1016\/S1470-2045(17)30441-2"},{"key":"5357_CR9","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/S1470-2045(17)30414-X","volume":"18","author":"A Mahajan","year":"2017","unstructured":"Mahajan A, Ahmed S, McAleer MF, Weinberg JS, Li J, Brown P, Settle S, Prabhu SS, Lang FF, Levine N, McGovern S, Sulman E, McCutcheon IE, Azeem S, Cahill D, Tatsui C, Heimberger AB, Ferguson S, Ghia A, Demonte F, Raza S, Guha-Thakurta N, Yang J, Sawaya R, Hess KR, Rao G (2017) Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial. Lancet Oncol 18:1040\u20131048. https:\/\/doi.org\/10.1016\/S1470-2045(17)30414-X","journal-title":"Lancet Oncol"},{"issue":"3","key":"5357_CR10","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.ijrobp.2018.10.038","volume":"103","author":"EJ Lehrer","year":"2019","unstructured":"Lehrer EJ, Peterson JL, Zaorsky NG, Brown PD, Sahgal A, Chiang VL, Chao ST, Sheehan JP, Trifiletti DM (2019) Single versus multifraction stereotactic radiosurgery for large brain metastases: an international Meta-analysis of 24 trials. Int J Radiat Oncol Biol Phys 103(3):618\u2013630. https:\/\/doi.org\/10.1016\/j.ijrobp.2018.10.038","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"5357_CR11","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13014-021-01802-9","volume":"16","author":"G Minniti","year":"2021","unstructured":"Minniti G, Niyazi M, Andratschke N, Guckenberger M, Palmer JD, Shih HA, Lo SS, Soltys S, Russo I, Brown PD, Belka C (2021) Current status and recent advances in resection cavity irradiation of brain metastases. Radiat Oncol 16(1):73. https:\/\/doi.org\/10.1186\/s13014-021-01802-9","journal-title":"Radiat Oncol"},{"key":"5357_CR12","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.ijrobp.2013.03.037","volume":"86","author":"G Minniti","year":"2013","unstructured":"Minniti G, Esposito V, Clarke E, Scaringi C, Lanzetta G, Salvati M, Raco A, Bozzao A, Maurizi Enrici R (2013) Multidose stereotactic radiosurgery (9 Gy \u00d7 3) of the postoperative resection cavity for treatment of large brain metastases. Int J Radiat Oncol Biol Phys 86:623\u2013629. https:\/\/doi.org\/10.1016\/j.ijrobp.2013.03.037","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5357_CR13","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s11060-014-1417-2","volume":"118","author":"KA Ahmed","year":"2014","unstructured":"Ahmed KA, Freilich JM, Abuodeh Y, Figura N, Patel N, Sarangkasiri S, Chinnaiyan P, Yu HH, Etame AB, Rao NG (2014) Fractionated stereotactic radiotherapy to the post-operative cavity for radioresistant and radiosensitive brain metastases. J Neurooncol 118:179\u2013186. https:\/\/doi.org\/10.1007\/s11060-014-1417-2","journal-title":"J Neurooncol"},{"key":"5357_CR14","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1227\/NEU.0000000000001096","volume":"79","author":"KR Patel","year":"2016","unstructured":"Patel KR, Burri SH, Asher AL, Crocker IR, Fraser RW, Zhang C, Chen Z, Kandula S, Zhong J, Press RH, Olson JJ, Oyesiku NM, Wait SD, Curran WJ, Shu HK, Prabhu RS (2016) Comparing preoperative with postoperative stereotactic radiosurgery for resectable brain metastases: A Multi-institutional analysis. Neurosurgery 79:279\u2013285. https:\/\/doi.org\/10.1227\/NEU.0000000000001096","journal-title":"Neurosurgery"},{"key":"5357_CR15","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s11060-017-2394-z","volume":"132","author":"G Minniti","year":"2017","unstructured":"Minniti G, Paolini S, D\u2019Andrea G, Lanzetta G, Cicone F, Confaloni V, Bozzao A, Esposito V, Osti M (2017) Outcomes of postoperative stereotactic radiosurgery to the resection cavity versus stereotactic radiosurgery alone for melanoma brain metastases. J Neurooncol 132:455\u2013462. https:\/\/doi.org\/10.1007\/s11060-017-2394-z","journal-title":"J Neurooncol"},{"key":"5357_CR16","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.ijrobp.2019.08.054","volume":"105","author":"P Navarria","year":"2019","unstructured":"Navarria P, Pessina F, Clerici E, Franceschini D, Gay LG, De Rose F, Renna I, D\u2019Agostino G, Franzese C, Comito T, Tomatis S, Nibali MC, Leonetti A, Puglisi G, Bello L, Scorsetti M (2019) Surgery followed by hypofractionated radiosurgery on the tumor bed in oligometastatic patients with large brain Metastases. Results of phase 2 study. Int J Radiat Oncol Biol Phys 105:1095\u20131105. https:\/\/doi.org\/10.1016\/j.ijrobp.2019.08.054","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5357_CR17","doi-asserted-by":"publisher","first-page":"E860E869","DOI":"10.1093\/neuros\/nyz162","volume":"85","author":"H Soliman","year":"2019","unstructured":"Soliman H, Myrehaug S, Tseng CL, Ruschin M, Hashmi A, Mainprize T, Spears J, Das S, Yang V, da Costa L, Maralani P, Heyn C, Atenafu EG, Sahgal A (2019) Image Guided, Linac-Based, surgical Cavity-Hypofractionated stereotactic radiotherapy in 5 daily fractions for brain metastases. Neurosurgery 85:E860E869. https:\/\/doi.org\/10.1093\/neuros\/nyz162","journal-title":"Neurosurgery"},{"key":"5357_CR18","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.ijrobp.2019.12.002","volume":"106","author":"S Faruqi","year":"2020","unstructured":"Faruqi S, Ruschin M, Soliman H, Myrehaug S, Zeng KL, Husain Z, Atenafu E, Tseng CL, Das S, Perry J, Maralani P, Heyn C, Mainprize T, Sahgal A (2020) Adverse radiation effect after hypofractionated stereotactic radiosurgery in 5 daily fractions for surgical cavities and intact brain metastases. Int J Radiat Oncol Biol Phys 106:772\u2013779. https:\/\/doi.org\/10.1016\/j.ijrobp.2019.12.002","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"5357_CR19","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jamaoncol.2020.4630","volume":"6","author":"KA Eitz","year":"2020","unstructured":"Eitz KA, Lo SS, Soliman H, Sahgal A, Theriault A, Pinkham MB, Foote MC, Song AJ, Shi W, Redmond KJ, Gui C, Kumar AMS, Machtay M, Meyer B, Combs SE (2020) Multi- institutional analysis of prognostic factors and outcomes after hypofractionated stereotactic radiotherapy to the resection cavity in patients with brain metastases. JAMA Oncol 6(12):1901\u20131909. https:\/\/doi.org\/10.1001\/jamaoncol.2020.4630","journal-title":"JAMA Oncol"},{"issue":"1","key":"5357_CR20","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ijrobp.2023.07.040","volume":"118","author":"R Upadhyay","year":"2024","unstructured":"Upadhyay R, Ayan AS, Jain S, Klamer BG, Perlow HK, Zoller W, Blakaj DM, Beyer S, Grecula J, Arnett A, Thomas E, Chakravarti A, Raval RR, Palmer JD (2024) Dose- volume tolerance of the brain and predictors of radiation necrosis after 3-Fraction radiosurgery for brain metastases: A large Single-Institutional analysis. Int J Radiat Oncol Biol Phys 118(1):275\u2013284. https:\/\/doi.org\/10.1016\/j.ijrobp.2023.07.040","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5357_CR21","doi-asserted-by":"publisher","unstructured":"Joiner MC, van der Kogel A (2009) Basic clinical radiobiology, 4th edn. CRC. https:\/\/doi.org\/10.1201\/b15450","DOI":"10.1201\/b15450"},{"issue":"6","key":"5357_CR22","doi-asserted-by":"publisher","first-page":"e270","DOI":"10.1016\/S1470-2045(15)70057-4","volume":"16","author":"NU Lin","year":"2015","unstructured":"Lin NU, Lee EQ, Aoyama H, Barani IJ, Barboriak DP, Baumert BG, Bendszus M, Brown PD, Camidge DR, Chang SM, Dancey J, de Vries EG, Gaspar LE, Harris GJ, Hodi FS, Kalkanis SN, Linskey ME, Macdonald DR, Margolin K, Mehta MP, Schiff D, Soffietti R, Suh JH, van den Bent MJ, Vogelbaum MA, Wen PY (2015) Response assessment in Neuro-Oncology (RANO) group. Response assessment criteria for brain metastases: proposal from the RANO group. Lancet Oncol 16(6):e270\u2013e278. https:\/\/doi.org\/10.1016\/S1470-2045(15)70057-4","journal-title":"Lancet Oncol"},{"issue":"1","key":"5357_CR23","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00259-014-2886-4","volume":"42","author":"F Cicone","year":"2015","unstructured":"Cicone F, Minniti G, Romano A, Papa A, Scaringi C, Tavanti F, Bozzao A, Maurizi Enrici R, Scopinaro F (2015) Accuracy of F-DOPA PET and perfusion-MRI for differentiating radionecrotic from progressive brain metastases after radiosurgery. Eur J Nucl Med Mol Imaging 42(1):103\u2013111. https:\/\/doi.org\/10.1007\/s00259-014-2886-4","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"5357_CR24","doi-asserted-by":"publisher","first-page":"101624","DOI":"10.1016\/j.esmoop.2023.101624","volume":"8","author":"E Le Rhun","year":"2023","unstructured":"Le Rhun E, Weller M, van den Bent M, Brandsma D, Furtner J, Rud\u00e0 R, Schadendorf D, Seoane J, Tonn JC, Wesseling P, Wick W, Minniti G, Peters S, Curigliano G, Preusser M, EANO Guidelines Committee and ESMO Guidelines Committee (2023) Electronic address: clinicalguidelines@esmo.org. Leptomeningeal metastasis from solid tumours: EANO-ESMO clinical practice guideline for diagnosis, treatment and follow-up. ESMO Open 8(5):101624. https:\/\/doi.org\/10.1016\/j.esmoop.2023.101624","journal-title":"ESMO Open"},{"key":"5357_CR25","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1214\/aos\/1176350951","volume":"16","author":"RJ Gray","year":"1988","unstructured":"Gray RJ (1988) A class of K-Sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16:1141\u20131154","journal-title":"Ann Stat"},{"issue":"1","key":"5357_CR26","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ijrobp.2020.08.013","volume":"110","author":"MT Milano","year":"2021","unstructured":"Milano MT, Grimm J, Niemierko A, Soltys SG, Moiseenko V, Redmond KJ, Yorke E, Sahgal A, Xue J, Mahadevan A, Muacevic A, Marks LB, Kleinberg LR (2021) Single- and multifraction stereotactic radiosurgery Dose\/Volume tolerances of the brain. Int J Radiat Oncol Biol Phys 110(1):68\u201386. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.08.013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5357_CR27","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.prro.2018.04.010","volume":"8","author":"C Gui","year":"2018","unstructured":"Gui C, Moore J, Grimm J, Kleinberg L, McNutt T, Shen C, Chen L, Bettegowda C, Lim M, Redmond KJ (2018) Local recurrence patterns after postoperative stereotactic radiation surgery to resected brain metastases: A quantitative analysis to guide target delineation. Pract Radiat Oncol 8:388\u2013396. https:\/\/doi.org\/10.1016\/j.prro.2018.04.010","journal-title":"Pract Radiat Oncol"},{"key":"5357_CR28","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s11060-018-2885-6","volume":"139","author":"AMS Kumar","year":"2018","unstructured":"Kumar AMS, Miller J, Hoffer SA, Mansur DB, Coffey M, Lo SS, Sloan AE, Machtay M (2018) Postoperative hypofractionated stereotactic brain radiation (HSRT) for resected brain metastases: improved local control with higher BED10. J Neurooncol 139:449\u2013454. https:\/\/doi.org\/10.1007\/s11060-018-2885-6","journal-title":"J Neurooncol"},{"key":"5357_CR29","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s11060-019-03308-7","volume":"145","author":"HB Musunuru","year":"2019","unstructured":"Musunuru HB, Witt JS, Yadav P, Francis DM, Kuczmarska-Haas A, Labby ZE, Bassetti MF, Howard SP, Baschnagel AM (2019) Impact of adjuvant fractionated stereotactic radiotherapy dose on local control of brain metastases. J Neurooncol 145:385\u2013390. https:\/\/doi.org\/10.1007\/s11060-019-03308-7","journal-title":"J Neurooncol"},{"key":"5357_CR30","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s11060-019-03383-w","volume":"146","author":"S Garimall","year":"2020","unstructured":"Garimall S, Shanker M, Johns E, Watkins T, Olson S, Huo M, Foote MC, Pinkham MB (2020) Evidence of dose-response following hypofractionated stereotactic radiotherapy to the cavity after surgery for brain metastases. J Neurooncol 146:357\u2013362. https:\/\/doi.org\/10.1007\/s11060-019-03383-w","journal-title":"J Neurooncol"},{"issue":"3","key":"5357_CR31","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.radonc.2011.01.011","volume":"98","author":"R Wiggenraad","year":"2011","unstructured":"Wiggenraad R, Verbeek-de Kanter A, Kal HB, Taphoorn M, Vissers T, Struikmans H (2011) Dose-effect relation in stereotactic radiotherapy for brain metastases. A systematic review. Radiother Oncol 98(3):292\u2013297. https:\/\/doi.org\/10.1016\/j.radonc.2011.01.011","journal-title":"Radiother Oncol"},{"key":"5357_CR32","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13014-018-1040-z","volume":"13","author":"CM van Leeuwen","year":"2018","unstructured":"van Leeuwen CM, Oei AL, Crezee J, Bel A, Franken NAP, Stalpers LJA, Kok HP (2018) The Alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies. Radiat Oncol 13:96. https:\/\/doi.org\/10.1186\/s13014-018-1040-z","journal-title":"Radiat Oncol"},{"key":"5357_CR33","doi-asserted-by":"publisher","first-page":"111067","DOI":"10.1016\/j.radonc.2025.111067","volume":"211","author":"J de Boisanger","year":"2025","unstructured":"de Boisanger J, Tran A, Benjamin P, Konadu J, Henderson J, Thomas K, Dreibe S, Hoff R, Brewer M, Reverberi C, van As N, Creak A, Solda F, Welsh L, Rees J, Rosenfelder N (2025) Dose-response modelling of stereotactic radiosurgery for brain metastases: preliminary prospective data from the SAFER study (IRAS 276567). Radiother Oncol 211:111067. https:\/\/doi.org\/10.1016\/j.radonc.2025.111067","journal-title":"Radiother Oncol"},{"issue":"1070","key":"5357_CR34","doi-asserted-by":"publisher","first-page":"20160666","DOI":"10.1259\/bjr.20160666","volume":"90","author":"S Baliga","year":"2017","unstructured":"Baliga S, Garg MK, Fox J, Kalnicki S, Lasala PA, Welch MR, Tom\u00e9 WA, Ohri N (2017) Fractionated stereotactic radiation therapy for brain metastases: a systematic review with tumour control probability modelling. Br J Radiol 90(1070):20160666. https:\/\/doi.org\/10.1259\/bjr.20160666","journal-title":"Br J Radiol"},{"key":"5357_CR35","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.radonc.2020.12.011","volume":"156","author":"N Andruska","year":"2021","unstructured":"Andruska N, Kennedy WR, Bonestroo L, Anderson R, Huang Y, Robinson CG, Abraham C, Tsien C, Knutson N, Rich KM, Spencer C, Huang J (2021) Dosimetric predictors of symptomatic radiation necrosis after five-fraction radiosurgery for brain metastases. Radiother Oncol 156:181\u2013187. https:\/\/doi.org\/10.1016\/j.radonc.2020.12.011","journal-title":"Radiother Oncol"},{"key":"5357_CR36","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.ijrobp.2019.11.022","volume":"106","author":"S Shi","year":"2020","unstructured":"Shi S, Sandhu N, Jin MC et al (2020) Stereotactic radiosurgery for resected brain metastases: single-institutional experience of over 500 cavities. Int J Radiat Oncol Biol Phys 106:764\u2013771. https:\/\/doi.org\/10.1016\/j.ijrobp.2019.11.022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5357_CR37","doi-asserted-by":"publisher","unstructured":"Ojerholm E, Lee JYK, Thawani JP et al (2014) Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis. J Neurosurg 121:75\u201383. https:\/\/doi.org\/10.3171\/2014.6.GKS14708","DOI":"10.3171\/2014.6.GKS14708"},{"key":"5357_CR38","doi-asserted-by":"publisher","unstructured":"Johnson MD, Avkshtol V, Baschnagel AM et al (2016) Surgical resection of brain metastases and the risk of leptomeningeal recurrence in patients treated with stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 94:537\u2013543. https:\/\/doi.org\/10.1016\/j.ijrobp.2015.11.022","DOI":"10.1016\/j.ijrobp.2015.11.022"},{"key":"5357_CR39","doi-asserted-by":"publisher","unstructured":"Foreman PM, Jackson BE, Singh KP et al (2018) Postoperative radiosurgery for the treatment of metastatic brain tumor: evaluation of local failure and leptomeningeal disease. J Clin Neurosci 49:48\u201355. https:\/\/doi.org\/10.1016\/j.jocn.2017.12.009","DOI":"10.1016\/j.jocn.2017.12.009"},{"issue":"12","key":"5357_CR40","doi-asserted-by":"publisher","first-page":"e003730","DOI":"10.1136\/jitc-2021-003730","volume":"9","author":"G Minniti","year":"2021","unstructured":"Minniti G, Lanzetta G, Capone L, Giraffa M, Russo I, Cicone F, Bozzao A, Alongi F, Nicosia L, Fineschi G, Marchetti L, Tufo T, Bianciardi F, Esposito V, Gentile P, Paolini S (2021) Leptomeningeal disease and brain control after postoperative stereotactic radiosurgery with or without immunotherapy for resected brain metastases. J Immunother Cancer 9(12):e003730. https:\/\/doi.org\/10.1136\/jitc-2021-003730","journal-title":"J Immunother Cancer"},{"key":"5357_CR41","doi-asserted-by":"publisher","first-page":"noaf182","DOI":"10.1093\/neuonc\/noaf182","volume":"30","author":"RA El Shafie","year":"2025","unstructured":"El Shafie RA, Bernhardt D, Welzel T, Schiele A, Schmitt D, Thalmann P, Erdem S, Eichkorn T, Paul A, Lang K, K\u00f6nig L, Weykamp F, Adeberg S, Lentz-Hommertgen A, J\u00e4kel C, Bozorgmehr F, Thomas M, Sander A, Kieser M, Debus J, Rieken S (2025) Hypofractionated stereotactic radiotherapy versus Whole-Brain radiotherapy following brain metastasis Resection - Results of the ESTRON randomized phase 2 trial. Neuro Oncol Jul 30:noaf182. https:\/\/doi.org\/10.1093\/neuonc\/noaf182","journal-title":"Neuro Oncol"},{"key":"5357_CR42","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1001\/jamaoncol.2018.7204","volume":"5","author":"DN Cagney","year":"2019","unstructured":"Cagney DN, Lamba N, Sinha S et al (2019) Association of neurosurgical resection with development of pachymeningeal seeding in patients with brain metastases. JAMA Oncol 5:703\u2013709. https:\/\/doi.org\/10.1001\/jamaoncol.2018.7204","journal-title":"JAMA Oncol"},{"key":"5357_CR43","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1093\/neuonc\/noz049","volume":"21","author":"RS Prabhu","year":"2019","unstructured":"Prabhu RS, Turner BE, Asher AL et al (2019) A multi-institutional analysis of presentation and outcomes for leptomeningeal disease recurrence after surgical resection and radiosurgery for brain metastases. Neuro Oncol 21:1049\u20131059. https:\/\/doi.org\/10.1093\/neuonc\/noz049","journal-title":"Neuro Oncol"},{"key":"5357_CR44","doi-asserted-by":"publisher","first-page":"vdab036","DOI":"10.1093\/noajnl\/vdab036","volume":"3","author":"A Teyateeti","year":"2021","unstructured":"Teyateeti A, Brown PD, Mahajan A et al (2021) Outcome comparison of patients who develop leptomeningeal disease or distant brain recurrence after brain metastases resection cavity radiosurgery. Neurooncol Adv 3:vdab036. https:\/\/doi.org\/10.1093\/noajnl\/vdab036","journal-title":"Neurooncol Adv"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05357-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-025-05357-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05357-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:53:55Z","timestamp":1781628835000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-025-05357-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["5357"],"URL":"https:\/\/doi.org\/10.1007\/s11060-025-05357-7","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"assertion":[{"value":"12 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of San Pietro Hospital, Fate Bene Fratelli, Rome, as retrospective study (November 3rd, 2024 No103\/2024).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Giuseppe Minniti has received speaker and consultant honoraria from Servier, Pfizer, Astra-Zeneca, Novocure, Brainlab. All other authors have no relevant financial or non-financial interests to disclose.\u201d","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"175"}}